Ethosomes: Carrier for Enhanced Transdermal Drug Delivery System
暂无分享,去创建一个
[1] M. Malcangio,et al. The role of glia in the spinal cord in neuropathic and inflammatory pain. , 2015, Handbook of experimental pharmacology.
[2] Shivaprakash,et al. Ethosomes: A Novel Tool for Transdermal Drug Delivery , 2013 .
[3] A. Pathak,et al. PREPARATION AND EVALUATION OF CAPTOPRIL TRANSDERMAL PATCHES , 2011 .
[4] S. Talegaonkar,et al. DESIGN AND DEVELOPMENT OF O/W NANOEMULSION FOR THE TRANSDERMAL DELIVERY OF ONDANSETRON , 2011 .
[5] G. Satyam,et al. Ethosomes: A novel tool for drug delivery through the skin , 2010 .
[6] T. Sivakumar,et al. Ethosomes-A Priority in Transdermal Drug Delivery , 2010 .
[7] Sajal K. Das,et al. TRANSDERMAL IONTOPHORETIC DELIVERY OF ATENOLOL IN COMBINATION WITH PENETRATION ENHANCERS: OPTIMIZATION AND EVALUATION ON SOLUTION AND GELS , 2009 .
[8] A. Misra,et al. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. , 2009, Indian journal of experimental biology.
[9] J. Manosroi,et al. Novel Elastic Nanovesicles for Cosmeceutical and Pharmaceutical Applications , 2009 .
[10] K. Cal. Skin disposition of menthol after its application in the presence of drug substances , 2008, Biopharmaceutics & drug disposition.
[11] Yuefeng Rao,et al. In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers , 2008, AAPS PharmSciTech.
[12] D. Paolino,et al. Innovative Drug Delivery Systems for the Administration of Natural Compounds , 2007 .
[13] Dinesh Mishra,et al. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] O. Abdallah,et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. , 2006, International journal of pharmaceutics.
[15] M. L. González-Rodríguez,et al. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. , 2005, International journal of pharmaceutics.
[16] B. Godin,et al. Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. , 2005, Current drug delivery.
[17] E. Touitou,et al. Testosterone Ethosomes for Enhanced Transdermal Delivery , 2005, Drug delivery.
[18] J. Lademann,et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.
[19] A. Fahr,et al. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[20] G. Cevc. Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.
[21] S. Jain,et al. Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent , 2004 .
[22] B. Godin,et al. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[23] E. Touitou,et al. Drug delivery across the skin , 2002, Expert opinion on biological therapy.
[24] E. Touitou,et al. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.
[25] B. Godin,et al. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[26] G. E. El Maghraby,et al. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.
[27] J. Engblom,et al. The skin barrier from a lipid perspective. , 2000, Acta dermato-venereologica. Supplementum.
[28] J. Bouwstra,et al. Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. , 1999, The Journal of investigative dermatology.
[29] E. Eliav,et al. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[30] Y. Chien,et al. Novel methods of insulin delivery: an update. , 1998, Critical reviews in therapeutic drug carrier systems.
[31] N. Weiner,et al. Targeted delivery to the pilosebaceous unit via liposomes , 1996 .
[32] A. Schätzlein,et al. TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .
[33] R. Baker,et al. Transdermal delivery of levonorgestrel I: Alkanols as permeation enhancers in vitro , 1988 .
[34] R. Daynes,et al. Skin immunology: The Achilles heel to transdermal drug delivery☆ , 1987 .
[35] A. Freedman. Handbook of Experimental Pharmacology, vol 14. , 1972 .
[36] R. Scheuplein,et al. Permeability of the skin. , 1971, Physiological reviews.